Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact.
about
Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidencesExcessive dietary intake of vitamin A reduces skull bone thickness in mice.Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interactionIncreased resorptive activity and accompanying morphological alterations in osteoclasts derived from the oim/oim mouse model of osteogenesis imperfecta.Identification of a subpopulation of marrow MSC-derived medullary adipocytes that express osteoclast-regulating molecules: marrow adipocytes express osteoclast mediators.Vitamin a is a negative regulator of osteoblast mineralization.Parathyroid hormone-related protein induces spontaneous osteoclast formation via a paracrine cascadeEstrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association.I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss.Contributions to osteoclast biology from Japan.Both immune hormone IL-10 and parathormone tend to increase in serum of old osteoporotic people independently of 1, 25 dihydroxy vitamin D3CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via Toll-like receptor 9.In vitro mimics of bone remodeling and the vicious cycle of cancer in bone.The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.Low concentrations of zoledronic acid are better at regulating bone formation and repairAn active role for soluble and membrane intercellular adhesion molecule-1 in osteoclast activity in vitroEstrogens and androgens inhibit association of RANKL with the pre-osteoblast membrane through post-translational mechanisms.Models of Bone Remodelling and Associated Disorders
P2860
Q26863493-FF09A120-BF0E-4CF3-B67C-5443F7F1C5FBQ33585182-0D4C08C7-7F39-4DBF-9E82-A1B81E335F92Q33886695-3418FB40-8359-463D-98C8-F0CE058D2251Q34148428-15F1CE4B-3B9A-448A-A38C-42FB6CF3024FQ34323264-2FE95D51-7B9E-4AC6-A21F-3A1A02895850Q35067782-4615329B-992F-45AF-8282-06F27E843547Q35157083-5CEF6420-B711-479E-95BF-3F422E5C76ACQ35287635-9CE6F246-82DD-4F67-B8AE-C44056A67FBCQ36402985-67349684-EE9F-40FC-B88D-EE6E0ACECB6FQ37038278-9A76D266-BD1B-4AE4-AE39-355DE59698C2Q37497197-34D745B8-4C2D-4E90-80D2-C8D451E10C22Q38357169-2AA9ED2A-B4E5-4831-9D14-9E14165832F4Q39097612-309DF054-AA41-4616-93E7-9039F2C2CC43Q41649459-60FFC9A7-307C-482A-B92D-89260D31DD67Q41896403-C97C348A-3A73-433D-9E17-1521C0AD4C13Q42244040-1BF13387-2B86-41CF-B36B-A60A1B7076E8Q43636544-9FAE447E-DEE6-446F-B813-977F8350A052Q58572612-40F43F0A-DA24-495A-8FD4-B1776A7AC947
P2860
Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Osteoclast function is activat ...... nvolving cell-to-cell contact.
@en
type
label
Osteoclast function is activat ...... nvolving cell-to-cell contact.
@en
prefLabel
Osteoclast function is activat ...... nvolving cell-to-cell contact.
@en
P2093
P356
P1433
P1476
Osteoclast function is activat ...... nvolving cell-to-cell contact.
@en
P2093
Nakamura I
Takahashi N
Tsurukai T
P304
P356
10.1210/EN.137.5.2187
P407
P577
1996-05-01T00:00:00Z